Global Primary Angle Closure Glaucoma Market
Market Size in USD Million
CAGR :
% 
USD
269.55 Million
USD
440.77 Million
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 269.55 Million |
 Market Size (Forecast Year) |
USD 440.77 Million |
 CAGR |
% |
| Major Markets Players |
|
Global Primary Angle-Closure Glaucoma Market Segmentation, By Disease Type (Acute Angle-Closure Glaucoma and Chronic Angle-Closure Glaucoma), Type (Diagnosis and Treatment), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others) - Industry Trends and Forecast to 2032
Primary Angle-Closure Glaucoma Market Size
- The global primary angle-closure glaucoma market size was valued at USD 269.55 million in 2024 and is expected to reach USD 440.77 million by 2032, at a CAGR of 6.1% during the forecast period
- The market growth is largely driven by the increasing global prevalence of glaucoma, particularly in aging populations across Asia-Pacific and other developing regions, along with heightened awareness and improved diagnostic capabilities
- Furthermore, advancements in laser therapy, minimally invasive surgical techniques, and pharmaceutical innovations are providing effective treatment options, reinforcing the market’s momentum. These combined developments are positioning primary angle-closure glaucoma therapies as essential components in global ophthalmic care, thereby propelling sustained market expansion
Primary Angle-Closure Glaucoma Market Analysis
- Primary angle-closure glaucoma (PACG), a serious eye condition caused by a sudden or gradual blockage of the eye’s drainage channels, is becoming an increasingly critical focus in ophthalmic care due to its rapid progression and high risk of vision loss, especially in aging populations and genetically predisposed groups
- The rising demand for PACG management is primarily fueled by increasing global glaucoma awareness, enhanced access to diagnostic tools in emerging economies, and a growing geriatric population susceptible to elevated intraocular pressure
- North America dominated the primary angle-closure glaucoma market with the largest revenue share of 39.1% in 2024, supported by advanced healthcare infrastructure, favorable reimbursement policies, and increased uptake of laser-based and minimally invasive surgical treatments across the U.S. and Canada
- Asia-Pacific is expected to be the fastest growing region in the primary angle-closure glaucoma market during the forecast period due to expanding elderly populations, improved healthcare access, and national eye health programs, particularly in China, India, and Southeast Asia
- Chronic Angle-Closure Glaucoma dominated the primary angle-closure glaucoma market with a revenue share of 61.8% in 2024, owing to its higher prevalence, often asymptomatic progression, and increased detection through routine ophthalmic screening and awareness programs
Report Scope and Primary Angle-Closure Glaucoma Market Segmentation
|
Attributes |
Primary Angle-Closure Glaucoma Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
North America
Europe
Asia-Pacific
Middle East and Africa
South America
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, pricing analysis, brand share analysis, consumer survey, demography analysis, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
Primary Angle-Closure Glaucoma Market Trends
“Advancements in Laser Therapies and Minimally Invasive Surgical Techniques”
- A significant and accelerating trend in the global primary angle-closure glaucoma (PACG) market is the increasing adoption of advanced laser therapies and minimally invasive glaucoma surgeries (MIGS), aimed at improving safety, efficacy, and long-term intraocular pressure control. These developments are transforming the clinical management landscape for PACG across both developed and emerging regions
- For instance, laser peripheral iridotomy (LPI) is now a standard first-line treatment, with advanced devices from Iridex and Ellex offering more precise energy delivery and reduced complications. Similarly, MIGS devices such as iStent and Hydrus Microstent are gaining traction for their ability to provide effective drainage with minimal trauma
- Innovations in imaging, including anterior segment optical coherence tomography (AS-OCT), are enabling ophthalmologists to better assess angle structure and plan targeted interventions. Furthermore, combining cataract surgery with goniosynechialysis or stenting is proving particularly effective in managing chronic PACG
- The integration of advanced diagnostic and surgical solutions allows for earlier intervention, faster recovery, and reduced dependence on long-term medication. These technologies are increasingly adopted by eye care centers seeking to deliver high-standard, patient-centric treatment
- This trend toward safer, less invasive, and more precise treatments is reshaping expectations for glaucoma care. As a result, companies are focusing on developing compact laser platforms and improved micro-implants tailored for PACG patients
- The demand for streamlined, minimally invasive glaucoma care is rising steadily across both hospital and ambulatory settings, as healthcare providers and patients asuch as seek better outcomes, fewer complications, and enhanced quality of life
Primary Angle-Closure Glaucoma Market Dynamics
Driver
“Growing Burden of Glaucoma and Increasing Geriatric Population”
- The increasing prevalence of primary angle-closure glaucoma globally, especially in aging populations across Asia and Latin America, is a key driver for the expanding demand for early diagnosis and treatment options
- For instance, in 2024, the World Glaucoma Association emphasized the urgency of addressing PACG, which accounts for nearly half of glaucoma-related blindness in some Asian countries. As awareness spreads, more healthcare systems are integrating glaucoma screening into routine eye care services
- As the elderly population continues to rise, so does the number of individuals with narrow angles and shallow anterior chambers, elevating the risk of PACG and highlighting the importance of timely interventions
- Furthermore, increased investments in ophthalmology infrastructure, growing adoption of diagnostic imaging technologies such as gonioscopy and OCT, and better-trained eye care professionals are making earlier detection and management of PACG more accessible
- The growing emphasis on preventing irreversible blindness and maintaining long-term visual health in seniors is significantly driving the adoption of both medical and surgical glaucoma solutions in hospitals, specialty clinics, and ambulatory care centers
Restraint/Challenge
“Low Awareness and Limited Access in Low-Income Regions”
- A major challenge in the primary angle-closure glaucoma market is the low level of awareness and limited access to advanced diagnostics and treatments in rural and low-income regions
- For instance, studies have shown that over 60% of PACG cases in underserved areas go undetected until irreversible vision loss occurs. Limited ophthalmologist availability and lack of diagnostic tools such as AS-OCT in primary care settings further hinder early identification
- Barriers such as high treatment costs, inadequate insurance coverage, and a lack of public health screening programs continue to impede timely intervention. Misconceptions about glaucoma being curable or non-serious also delay patient engagement
- Addressing these issues requires improved health education, mobile eye care units, and strategic collaborations between governments, NGOs, and healthcare providers to enhance accessibility and affordability
- Overcoming these systemic barriers through scalable outreach initiatives and low-cost treatment alternatives will be essential for expanding PACG care delivery and reducing the global disease burden
Primary Angle-Closure Glaucoma Market Scope
The market is segmented on the basis of disease type, type, end user, and distribution channel.
- By Disease Type
On the basis of disease type, the primary angle-closure glaucoma market is segmented into acute angle-closure glaucoma and chronic angle-closure glaucoma. The chronic angle-closure glaucoma segment dominated the market with the largest market revenue share of 61.8% in 2024, owing to its higher prevalence, gradual progression, and late symptom onset which often delays diagnosis. Chronic cases require consistent monitoring and long-term treatment, driving demand for laser interventions, pharmaceuticals, and minimally invasive surgical options. The segment continues to benefit from improved detection rates due to increased public health awareness and routine eye screenings in high-risk populations.
The acute angle-closure glaucoma segment is anticipated to witness steady growth from 2025 to 2032, driven by the need for emergency interventions and advancements in rapid-access laser treatment facilities. Although less prevalent than chronic cases, acute presentations demand immediate medical attention and continue to be a clinical priority in emergency ophthalmology care
- By Type
On the basis of type, the primary angle-closure glaucoma market is segmented into diagnosis and treatment. The treatment segment dominated the market with the largest market revenue share of 68.4% in 2024, driven by the widespread adoption of laser therapies, intraocular pressure-lowering drugs, and surgical interventions. This segment benefits from technological advancements in laser platforms, expanding access to outpatient MIGS procedures, and increasing patient preference for long-term pressure management options.
The diagnosis segment is anticipated to witness notable growth from 2025 to 2032, supported by the rising demand for early detection tools such as gonioscopy and anterior segment OCT. Public and private eye care institutions are increasingly incorporating advanced imaging systems to improve angle assessment accuracy, enabling earlier intervention and reducing disease progression.
- By End User
On the basis of end user, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and others. The hospitals segment dominated the market with the largest market revenue share of 47.6% in 2024, due to the comprehensive services offered for both acute and chronic PACG cases, including advanced diagnostics, surgical capabilities, and post-operative care. Hospitals remain primary centers for high-risk cases and serve as referral hubs for complex glaucoma management.
The ambulatory surgical centers segment is expected to witness the fastest growth rate from 2025 to 2032, fueled by the rising popularity of cost-effective, minimally invasive outpatient procedures. These centers offer shorter recovery times, lower procedural costs, and convenience for patients undergoing laser or MIGS treatments, particularly in urban and semi-urban areas.
- By Distribution Channel
On the basis of distribution channel, the primary angle-closure glaucoma market is segmented into direct tender, retail sales, and others. The direct tender segment dominated the market with the largest market revenue share of 54.9% in 2024, driven by the large-scale procurement of ophthalmic equipment, laser systems, and surgical tools by government hospitals and institutional healthcare networks. Direct tenders ensure cost control and facilitate the deployment of PACG treatment technologies in public health programs.
The retail sales segment is anticipated to grow steadily during the forecast period, supported by the increasing availability of glaucoma medications, diagnostic kits, and eye care supplements across pharmacies and e-commerce platforms. As more patients seek accessible solutions for managing chronic glaucoma symptoms, the retail channel is becoming an essential component of the overall treatment ecosystem.
Primary Angle-Closure Glaucoma Market Regional Analysis
- North America dominated the primary angle-closure glaucoma market with the largest revenue share of 39.1% in 2024, supported by advanced healthcare infrastructure, favorable reimbursement policies, and increased uptake of laser-based and minimally invasive surgical treatments across the U.S. and Canada
- Patients in the region benefit from early screening programs, insurance coverage for ophthalmic procedures, and increased availability of cutting-edge laser therapies and minimally invasive surgical techniques for glaucoma management
- This strong regional performance is further supported by an aging population, increasing investments in ophthalmology research, and the presence of key market players, making North America a hub for innovation and early adoption of advanced PACG treatment solutions across hospital and outpatient settings
U.S. Primary Angle-Closure Glaucoma Market Insight
The U.S. primary angle-closure glaucoma market captured the largest revenue share of 79.4% in 2024 within North America, driven by early disease detection, established ophthalmic infrastructure, and widespread access to advanced laser and surgical treatments. The increasing prevalence of glaucoma among the aging population and rising awareness initiatives by organizations such as the Glaucoma Research Foundation are contributing to early diagnosis and treatment. Moreover, continuous innovations in diagnostic imaging and minimally invasive procedures, along with robust insurance coverage, are propelling market growth across both urban and rural care settings.
Europe Primary Angle-Closure Glaucoma Market Insight
The Europe primary angle-closure glaucoma market is projected to grow at a steady CAGR throughout the forecast period, supported by favorable healthcare policies, growing awareness of glaucoma-related vision loss, and the availability of advanced treatment options. The increasing elderly population, combined with national vision screening programs in countries such as France and Germany, is driving early-stage detection. Europe’s strong emphasis on public health, coupled with enhanced reimbursement for ophthalmic procedures, is encouraging greater patient engagement and uptake of laser therapies and surgical interventions.
U.K. Primary Angle-Closure Glaucoma Market Insight
The U.K. primary angle-closure glaucoma market is anticipated to grow at a notable CAGR during the forecast period, driven by the National Health Service’s (NHS) support for glaucoma screening and growing public health awareness. Rising incidences of angle-closure glaucoma among older adults and ethnic minorities are prompting targeted initiatives for early diagnosis and treatment access. Technological advancements in imaging and laser-based solutions are also supporting the U.K.’s focus on reducing glaucoma-related blindness through proactive care strategies.
Germany Primary Angle-Closure Glaucoma Market Insight
The Germany primary angle-closure glaucoma market is expected to expand at a considerable CAGR during the forecast period, fueled by an aging demographic, increasing adoption of high-precision diagnostic tools, and access to cutting-edge treatment methods. Germany’s advanced healthcare infrastructure and emphasis on preventive ophthalmology foster early diagnosis of PACG, while government-supported vision screening programs ensure consistent patient monitoring. The market is further supported by strong collaboration between medical institutions and device manufacturers in advancing glaucoma research.
Asia-Pacific Primary Angle-Closure Glaucoma Market Insight
The Asia-Pacific primary angle-closure glaucoma market is projected to grow at the fastest CAGR of 23.5% from 2025 to 2032, driven by high disease prevalence, especially in countries such as China, India, and Southeast Asia. Increased investment in healthcare infrastructure, growing awareness through national eye health programs, and the rise of mobile ophthalmic screening units are enhancing access to timely diagnosis and treatment. As the region undergoes rapid urbanization and aging, demand for laser procedures and surgical interventions is expanding across both metropolitan and rural areas.
Japan Primary Angle-Closure Glaucoma Market Insight
The Japan primary angle-closure glaucoma market is gaining momentum due to the country’s rapidly aging population, which is particularly vulnerable to PACG. High standards in ophthalmic care, combined with advanced diagnostic imaging and availability of MIGS procedures, are driving early-stage intervention and effective disease management. Japan's well-integrated healthcare system ensures that patients have access to both routine screening and high-end surgical solutions, promoting consistent market expansion.
India Primary Angle-Closure Glaucoma Market Insight
The India primary angle-closure glaucoma market accounted for the largest market revenue share in Asia-Pacific in 2024, driven by a rising geriatric population, increasing healthcare access, and growing efforts in early disease awareness. India’s National Programme for Control of Blindness & Visual Impairment (NPCBVI) has played a crucial role in glaucoma screening at the community level. The widespread deployment of mobile eye clinics and adoption of affordable laser and surgical options are making PACG treatment more accessible across both urban and rural areas, significantly contributing to regional market growth.
Primary Angle-Closure Glaucoma Market Share
The primary angle-closure glaucoma industry is primarily led by well-established companies, including:
- Johnson & Johnson Services, Inc. (U.S.)
- Aurolab (India)
- New World Medical, Inc. (U.S.)
- Sight Sciences (U.S.)
- NIDEK CO., LTD (Japan)
- BVI (U.S.)
- MicroSurgical Technology (U.S.)
- Bausch + Lomb (U.S.)
- Oertli Instrumente AG (Switzerland)
- Medisonic Equipments Pvt. Ltd. (India)
- Omni Lens Pvt. Ltd. (U.S.)
- Appasamy Associates Private Limited (India)
- NOVAEYE MEDICAL (Australia)
- ZEISS Group (Germany)
- Alcon Inc. (Switzerland)
- LIGHTMED (Taiwan)
- Reichert, Inc. (U.S.)
- NewVision Softcom & Consultancy Pvt. Ltd (India)
What are the Recent Developments in Global Primary Angle-Closure Glaucoma Market?
- In March 2024, Iridex Corporation, a leading provider of laser-based medical systems for ophthalmology, launched its next-generation Cyclo G6® Laser System with updated probe designs aimed at improving treatment precision for angle-closure glaucoma. The system enhances safety and efficacy in reducing intraocular pressure, particularly in chronic PACG cases. This development reinforces Iridex’s commitment to advancing non-invasive glaucoma therapies and improving patient outcomes through precision technology in laser interventions
- In February 2024, Santen Pharmaceutical Co., Ltd. announced a new clinical collaboration to evaluate combination therapy options involving its established glaucoma eye drops and laser trabeculoplasty for managing chronic primary angle-closure glaucoma in Asian populations. This collaboration reflects a growing focus on multimodal treatment strategies tailored to regional disease burdens and highlights the role of pharmaceutical innovation in chronic glaucoma care
- In January 2024, Alcon Inc. unveiled a significant expansion of its Glaucoma Surgical Training Program across Asia-Pacific, focusing on techniques for managing angle-closure glaucoma through minimally invasive glaucoma surgery (MIGS). The initiative aims to upskill ophthalmic surgeons in underserved markets, improving access to advanced treatment methods and reinforcing Alcon’s leadership in surgical ophthalmology solutions
- In October 2023, New World Medical, Inc., a U.S.-based glaucoma device company, received expanded regulatory approvals for its Ahmed ClearPath drainage devices in several Latin American countries for the treatment of advanced PACG. These devices offer a long-term solution for patients with elevated intraocular pressure unresponsive to conventional therapies. The expansion reflects New World Medical’s global strategy to address unmet needs in glaucoma management
- In September 2023, Ellex (a Lumibird Group company) introduced enhancements to its SLT (Selective Laser Trabeculoplasty) systems, improving energy delivery and targeting for early-stage primary angle-closure cases. The new features offer ophthalmologists greater control and reduce procedural variability, supporting more effective pressure reduction in patients with narrow angles or early closure. This innovation underscores the industry’s focus on optimizing non-invasive treatment options.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET end user coverage GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Epidemiology
- Regulatory Framework
- Pipeline analysis
- market overview
- drivers
- INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA
- INCREASING WOMEN POPULATION
- RISE IN GERIATRIC POPULATION
- ADVANCEMENTS IN SURGICAL TREATMENT OF THE DISEASE
- INCREASED ECONOMIC BURDEN
- RESTRAINTS
- HIGH SURGICAL COSTS OF PACG
- INADEQUATE REIMBURSEMENT SCENARIO
- DELAYED AND MISDIAGNOSIS OF PACG
- OPPORTUNITIES
- INCREASING GOVERNMENT INITIATIVES TOWARDS GLAUCOMA
- RECENT APPROVAL BY GOVERNING BODIES
- INCREASING INCIDENCES IN EMERGING MARKET
- RAPID TRANSITION FROM PACG MEDICATION TO SURGERIES
- CHALLENGES
- RISKS ASSOCIATED WITH SURGICAL PROCEDURES
- LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
- LIMITED ACCESS TO TREATMENT
- IMPACT OF COVID-19 ON GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISION BY MANUFACTURERS
- CONCLUSION
- global PRIMARY ANGLE CLOSURE GLAUCOMA Market, By DISEASE TYPE
- overview
- acute angle-closure glaucoma market
- chronic angle-closure glaucoma market
- GLOBAL primary angle-closure glaucoma MARKET, BY TYPE
- overview
- Diagnosis
- primary test
- GONIOSCOPY EXAMINATION
- SLIT-LAMP EXAMINATION
- AUTOMATIC STATIC PERIMETRY
- SECONDARY test
- ULTRASOUND BIOMICROSCOPY
- ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY (OCT)
- RETINAL OCT
- FUNDOSCOPY
- OTHERS
- Treatment
- Surgical Iridectomy
- TRABECULECTOMY
- Micro invasive glaucoma technique (MIGS)
- goniotomy
- Others
- GLOBAL primary angle-closure glaucoma MARKET, BY end user
- overview
- HoSpitals
- AMbulatory surgical Centers
- Specialty Clinics
- others
- GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY distribution channel
- overview
- direct tender
- retail sales
- Others
- GLOBAL primary angle-closure glaucoma MARKET, BY GEOGRAPHY
- OVERVIEW
- NORTH AMERICA
- U.S.
- CANADA
- MEXICO
- EUROPE
- GERMANY
- FRANCE
- ITALY
- U.K.
- SPAIN
- RUSSIA
- AUSTRIA
- NETHERLANDS
- HUNGARY
- POLAND
- SWITZERLAND
- TURKEY
- NORWAY
- LITHUANIA
- IRELAND
- REST OF EUROPE
- ASIA-PACIFIC
- JAPAN
- CHINA
- INDIA
- AUSTRALIA
- SINGAPORE
- SOUTH KOREA
- MALAYSIA
- THAILAND
- INDONESIA
- PHILIPPINES
- VIETNAM
- REST OF ASIA-PACIFIC
- SOuth america
- BRAZIL
- ARGENTINA
- PERU
- REST OF SOUTH AMERICA
- middle east and Africa
- SOUTH AFRICA
- EGYPT
- SAUDI ARABIA
- ISRAEL
- UAE
- KUWAIT
- REST OF MIDDLE EAST AND AFRICA
- Global primary angle-closure glaucoma Market: COMPANY landscape
- company share analysis: global
- company share analysis: north america
- company share analysis: europe
- company share analysis: Asia-Pacific
- SWOT
- company profiles
- johnson & johnson vision care, inc. (a subsidiary of johnson & johnson services, inc.)
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- bausch & lomb incorporated (a subsidiary of bausch health Companies Inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- alcon inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Zeiss International
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- NOVA EYE MEDICAL LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- NIDEK CO., LTD
- COMPANY SNAPShot
- product Portfolio
- RECENT DEVELOPMENTS
- allergan (a subsidiary of abbvie inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- APPASAMY ASSOCIATES
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- aurolab
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- BVI
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- LIGHTMED
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Luneau technology usa
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- medisonic equipments pvt. ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- microsurgical technology
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- new vision
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- New World Medical, Inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Oertli Instrumente AG
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- omni lens
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Reichert, inc. (A business unit of ametek.inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Sight Sciences, inc.
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- questionnaire
- related reports
List of Table
TABLE 1 Global Primary Angle-Closure Glaucoma Market, Pipeline Analysis
TABLE 2 NUMBER OF OPHTHALMOLOGISTS/MILLION POPULATIONS
TABLE 3 global Primary angle closure glaucoma market, By disease type, 2019-2028 (USD million)
TABLE 4 Global Acute-angle closure glaucoma in Primary angle closure glaucoma Market, By Region, 2019-2028 (USD Million)
TABLE 5 Global chronic angle-closure glaucoma in Primary angle closure glaucoma Market,By Region, 2019-2028 (USD Million)
TABLE 6 Global Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 7 Global Diagnosis in Primary Angle-Closure Glaucoma Market, By region, 2019-2028 (USD Million)
TABLE 8 Global Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 9 Global Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 10 Global Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 11 Global Treatment in Primary Angle-Closure Glaucoma Market, By Disease Type 2019-2028 (USD Million)
TABLE 12 Global Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 13 Global Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 14 Global Hospitals in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 15 Global Ambulatory Surgical Centers in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 16 Global Specialty Clinics in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 17 Global Others in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 18 Global Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 19 Global Direct Tender in Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 20 Global Retail Sales in Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 21 Global Others in Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 22 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 North America PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 24 North America PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 25 North America Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 26 North America Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 27 North America Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 28 North America Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 29 North America Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 30 North America Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 31 North America Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 32 U.S. PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 33 U.S. Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 34 U.S. Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 35 U.S. Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 36 U.S. Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 37 U.S. Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 38 U.S. Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 39 U.S. Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 40 CANADA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 41 CANADA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 42 CANADA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 43 CANADA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 44 CANADA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 45 CANADA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 46 CANADA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 47 CANADA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 48 MEXICO PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 49 MEXICO Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 50 MEXICO Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 51 MEXICO Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 52 MEXICO Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 53 MEXICO Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 54 MEXICO Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 55 MEXICO Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 56 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 57 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 58 EUROPE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 59 EUROPE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 60 EUROPE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 61 EUROPE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 62 EUROPE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 63 EUROPE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 64 EUROPE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 65 Germany PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 66 GERMANY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 67 GERMANY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 68 GERMANY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 69 GERMANY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 70 GERMANY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 71 GERMANY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 72 GERMANY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 73 FRANCE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 74 FRANCE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 75 FRANCE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 76 FRANCE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 77 FRANCE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 78 FRANCE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 79 FRANCE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 80 FRANCE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 81 ITALY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 82 ITALY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 83 ITALY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 84 ITALY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 85 ITALY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 86 ITALY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 87 ITALY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 88 ITALY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 89 U.K. PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 90 U.K. Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 91 U.K. Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 92 U.K. Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 93 U.K. Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 94 U.K. Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 95 U.K. Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 96 U.K. Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 97 SPAIN PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 98 SPAIN Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 99 SPAIN Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 100 SPAIN Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 101 SPAIN Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 102 SPAIN Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 103 SPAIN Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 104 SPAIN Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 105 RUSSIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 106 RUSSIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 107 RUSSIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 108 RUSSIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 109 RUSSIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 110 RUSSIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 111 RUSSIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 112 RUSSIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 113 AUSTRIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 114 AUSTRIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 115 AUSTRIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 116 AUSTRIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 117 AUSTRIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 118 AUSTRIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 119 AUSTRIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 120 AUSTRIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 121 NETHERLANDS PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 122 NETHERLANDS Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 123 NETHERLANDS Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 124 NETHERLANDS Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 125 NETHERLANDS Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 126 NETHERLANDS Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 127 NETHERLANDS Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 128 NETHERLANDS Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 129 HUNGARY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 130 HUNGARY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 131 HUNGARY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 132 HUNGARY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 133 HUNGARY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 134 HUNGARY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 135 HUNGARY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 136 HUNGARY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 137 POLAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 138 POLAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 139 POLAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 140 POLAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 141 POLAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 142 POLAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 143 POLAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 144 POLAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 145 SWITZERLAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 146 SWITZERLAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 147 SWITZERLAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 148 SWITZERLAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 149 SWITZERLAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 150 SWITZERLAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 151 SWITZERLAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 152 SWITZERLAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 153 TURKEY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 154 TURKEY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 155 TURKEY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 156 TURKEY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 157 TURKEY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 158 TURKEY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 159 TURKEY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 160 TURKEY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 161 NORWAY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 162 NORWAY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 163 NORWAY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 164 NORWAY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 165 NORWAY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 166 NORWAY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 167 NORWAY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 168 NORWAY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 169 LITHUANIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 170 LITHUANIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 171 LITHUANIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 172 LITHUANIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 173 LITHUANIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 174 LITHUANIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 175 LITHUANIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 176 LITHUANIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 177 IRELAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 178 IRELAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 179 IRELAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 180 IRELAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 181 IRELAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 182 IRELAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 183 IRELAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 184 IRELAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 185 REst of europe Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)
TABLE 186 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 187 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 188 ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 189 ASIA-PACIFIC Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 190 ASIA-PACIFIC Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 191 ASIA-PACIFIC Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 192 ASIA-PACIFIC Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 193 ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 194 ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 195 JAPAN PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 196 JAPAN Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 197 JAPAN Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 198 JAPAN Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 199 JAPAN Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 200 JAPAN Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 201 JAPAN Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 202 JAPAN Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 203 CHINA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 204 CHINA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 205 CHINA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 206 CHINA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 207 CHINA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 208 CHINA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 209 CHINA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 210 CHINA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 211 INDIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 212 INDIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 213 INDIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 214 INDIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 215 INDIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 216 INDIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 217 INDIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 218 INDIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 219 AUSTRALIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 220 AUSTRALIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 221 AUSTRALIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 222 AUSTRALIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 223 AUSTRALIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 224 AUSTRALIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 225 AUSTRALIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 226 AUSTRALIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 227 SINGAPORE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 228 SINGAPORE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 229 SINGAPORE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 230 SINGAPORE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 231 SINGAPORE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 232 SINGAPORE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 233 SINGAPORE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 234 SINGAPORE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 235 SOUTH KOREA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 236 SOUTH KOREA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 237 SOUTH KOREA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 238 SOUTH KOREA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 239 SOUTH KOREA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 240 SOUTH KOREA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 241 SOUTH KOREA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 242 SOUTH KOREA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 243 MALAYSIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 244 MALAYSIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 245 MALAYSIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 246 MALAYSIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 247 MALAYSIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 248 MALAYSIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 249 MALAYSIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 250 MALAYSIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 251 THAILAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 252 THAILAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 253 THAILAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 254 THAILAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 255 THAILAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 256 THAILAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 257 THAILAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 258 THAILAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 259 INDONESIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 260 INDONESIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 261 INDONESIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 262 INDONESIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 263 INDONESIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 264 INDONESIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 265 INDONESIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 266 INDONESIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 267 PHILIPPINES PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 268 PHILIPPINES Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 269 PHILIPPINES Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 270 PHILIPPINES Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 271 PHILIPPINES Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 272 PHILIPPINES Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 273 PHILIPPINES Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 274 PHILIPPINES Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 275 VIETNAM PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 276 VIETNAM Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 277 VIETNAM Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 278 VIETNAM Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 279 VIETNAM Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 280 VIETNAM Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 281 VIETNAM Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 282 VIETNAM Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 283 REst of ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)
TABLE 284 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 285 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 286 SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 287 SOUTH AMERICA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 288 SOUTH AMERICA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 289 SOUTH AMERICA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 290 SOUTH AMERICA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 291 SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 292 SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 293 BRAZIL PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 294 BRAZIL Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 295 BRAZIL Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 296 BRAZIL Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 297 BRAZIL Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 298 BRAZIL Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 299 BRAZIL Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 300 BRAZIL Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 301 ARGENTINA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 302 ARGENTINA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 303 ARGENTINA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 304 ARGENTINA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 305 ARGENTINA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 306 ARGENTINA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 307 ARGENTINA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 308 ARGENTINA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 309 PERU PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 310 PERU Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 311 PERU Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 312 PERU Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 313 PERU Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 314 PERU Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 315 PERU Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 316 PERU Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 317 REst of SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)
TABLE 318 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 319 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 320 MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 321 MIDDLE EAST AND AFRICA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 322 MIDDLE EAST AND AFRICA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 323 MIDDLE EAST AND AFRICA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 324 MIDDLE EAST AND AFRICA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 325 MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 326 MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 327 SOUTH AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 328 SOUTH AFRICA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 329 SOUTH AFRICA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 330 SOUTH AFRICA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 331 SOUTH AFRICA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 332 SOUTH AFRICA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 333 SOUTH AFRICA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 334 SOUTH AFRICA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 335 EGYPT PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 336 EGYPT Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 337 EGYPT Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 338 EGYPT Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 339 EGYPT Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 340 EGYPT Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 341 EGYPT Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 342 EGYPT Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 343 SAUDI ARABIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 344 SAUDI ARABIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 345 SAUDI ARABIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 346 SAUDI ARABIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 347 SAUDI ARABIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 348 SAUDI ARABIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 349 SAUDI ARABIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 350 SAUDI ARABIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 351 ISRAEL PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 352 ISRAEL Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 353 ISRAEL Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 354 ISRAEL Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 355 ISRAEL Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 356 ISRAEL Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 357 ISRAEL Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 358 ISRAEL Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 359 UAE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 360 UAE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 361 UAE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 362 UAE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 363 UAE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 364 UAE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 365 UAE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 366 UAE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 367 KUWAIT PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 368 KUWAIT Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 369 KUWAIT Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 370 KUWAIT Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 371 KUWAIT Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 372 KUWAIT Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 373 KUWAIT Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 374 KUWAIT Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 375 REst of MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)
List of Figure
FIGURE 1 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: segmentation
FIGURE 2 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET : data triangulation
FIGURE 3 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: Global VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: MULTIVARIATE MODELLING
FIGURE 7 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DBMR MARKET POSITION GRID
FIGURE 9 Global primary angle-closure glaucoma market: MARKET end user coverage GRID
FIGURE 10 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 Global primary angle-closure glaucoma market: SEGMENTATION
FIGURE 12 NORTH AMERICA is expected to DOMINATE and asia-pacific is growing at the fastest pace in global primary angle-closure glaucoma market IN the forecast period of 2021 to 2028
FIGURE 13 INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA and ADVANCEMENT IN SURGICAL TREATMENT OF THE DISEASE are DRIVing THE global primary angle-closure glaucoma market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 14 ACUTE ANGLE-CLOSURE GLAUCOMA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET IN 2021 & 2028
FIGURE 15 asia-PACIFIC is the fastest growing market in global primary angle-closure glaucoma market in the forecast period of 2021 to 2028
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
FIGURE 17 global Primary angle closure glaucoma market: By disease type, 2020
FIGURE 18 global Primary angle closure glaucoma market: By disease type, 2020-2028 (USD Million)
FIGURE 19 global Primary angle closure glaucoma market: By disease type, CAGR (2020-2028)
FIGURE 20 global Primary angle closure glaucoma market: By disease type, LIFELINE CURVE
FIGURE 21 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE, 2020
FIGURE 22 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE 2020-2028 (USD Million)
FIGURE 23 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE, CAGR (2021-2028)
FIGURE 24 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE, LIFELINE CURVE
FIGURE 25 global Primary Angle-Closure Glaucoma market: BY end users, 2020
FIGURE 26 global Primary Angle-Closure Glaucoma market: BY end users, 2020-2028 (USD Million)
FIGURE 27 global Primary Angle-Closure Glaucoma market: BY end users, CAGR (2021-2028)
FIGURE 28 global Primary Angle-Closure Glaucoma market: BY end users, LIFELINE CURVE
FIGURE 29 global Primary Angle-Closure Glaucoma market: BY distribution channel, 2020
FIGURE 30 global Primary Angle-Closure Glaucoma market: BY distribution channel, 2020-2028 (USD Million)
FIGURE 31 global Primary Angle-Closure Glaucoma market: BY distribution channel, CAGR (2021-2028)
FIGURE 32 global Primary Angle-Closure Glaucoma market: BY distribution, LIFELINE CURVE
FIGURE 33 GLobal PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 34 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 35 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 36 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 37 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2020-2028)
FIGURE 38 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 39 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 40 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 43 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 44 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 45 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 46 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 47 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 48 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 49 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 50 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 51 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 52 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 53 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 54 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 55 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 56 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 57 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 58 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 59 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 60 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 61 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 62 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 63 Global primary angle-closure glaucoma market: company share 2020 (%)
FIGURE 64 north america primary angle-closure glaucoma market: company share 2020 (%)
FIGURE 65 europe primary angle-closure glaucoma market: company share 2020 (%)
FIGURE 66 Asia-Pacific primary angle-closure glaucoma market: company share 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
